» Articles » PMID: 21843517

Impact of Divalent Metal Ions on Regulation of Adenylyl Cyclase Isoforms by Forskolin Analogs

Overview
Date 2011 Aug 17
PMID 21843517
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian membranous adenylyl cyclases (mACs) play an important role in transmembrane signalling events in almost every cell and represent an interesting drug target. Forskolin (FS) is an invaluable research tool, activating AC isoforms 1-8. However, there is a paucity of AC isoform-selective FS analogs. Therefore, we examined the effects of FS and six FS derivatives on recombinant ACs 1, 2 and 5, representing members of different mAC families. Correlations of the pharmacological properties of the different AC isoforms revealed pronounced differences between ACs 1, 2 and 5. Additionally, potencies and efficacies of FS derivatives changed for any given AC isoform, depending on the metal ion, Mg(2+) or Mn(2+). The most striking effects of Mg(2+) and Mn(2+) on the diterpene profile were observed for AC2 where the large inhibitory effect of BODIPY-FS in the presence of Mg(2+) was considerably reduced in the presence of Mn(2+). Sequence alignment and docking experiments confirmed an exceptional position of AC2 compared to ACs 1 and 5 with respect to the structural environment of the catalytic core and cation-dependent diterpene effects. In conclusion, mAC isoforms 1, 2 and 5 exhibit a distinct pharmacological diterpene profile, depending on the divalent cation present. mAC crystal structures and modelling/docking studies provided an explanation for the pharmacological differences between the AC isoforms. Our study constitutes an important step towards the development of isoform-specific diterpenes exhibiting stimulatory or inhibitory effects.

Citing Articles

Regulatory sites of CaM-sensitive adenylyl cyclase AC8 revealed by cryo-EM and structural proteomics.

Khanppnavar B, Schuster D, Lavriha P, Uliana F, Ozel M, Mehta V EMBO Rep. 2024; 25(3):1513-1540.

PMID: 38351373 PMC: 10933263. DOI: 10.1038/s44319-024-00076-y.


Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Ostrom K, LaVigne J, Brust T, Seifert R, Dessauer C, Watts V Physiol Rev. 2021; 102(2):815-857.

PMID: 34698552 PMC: 8759965. DOI: 10.1152/physrev.00013.2021.


International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Dessauer C, Watts V, Ostrom R, Conti M, Dove S, Seifert R Pharmacol Rev. 2017; 69(2):93-139.

PMID: 28255005 PMC: 5394921. DOI: 10.1124/pr.116.013078.


Cardiac cAMP: production, hydrolysis, modulation and detection.

Boularan C, Gales C Front Pharmacol. 2015; 6:203.

PMID: 26483685 PMC: 4589651. DOI: 10.3389/fphar.2015.00203.


Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor.

Conley J, Brand C, Bogard A, Pratt E, Xu R, Hockerman G J Pharmacol Exp Ther. 2013; 347(2):276-87.

PMID: 24008337 PMC: 3807067. DOI: 10.1124/jpet.113.207449.


References
1.
Laurenza A, Khandelwal Y, de Souza N, Rupp R, Metzger H, Seamon K . Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Mol Pharmacol. 1987; 32(1):133-9. View

2.
Zhang G, Liu Y, Ruoho A, Hurley J . Structure of the adenylyl cyclase catalytic core. Nature. 1997; 386(6622):247-53. DOI: 10.1038/386247a0. View

3.
Mou T, Gille A, Suryanarayana S, Richter M, Seifert R, Sprang S . Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine- and pyrimidine nucleotide inhibitors. Mol Pharmacol. 2006; 70(3):878-86. DOI: 10.1124/mol.106.026427. View

4.
Seifert R, Lee T, Lam V, Kobilka B . Reconstitution of beta2-adrenoceptor-GTP-binding-protein interaction in Sf9 cells--high coupling efficiency in a beta2-adrenoceptor-G(s alpha) fusion protein. Eur J Biochem. 1998; 255(2):369-82. DOI: 10.1046/j.1432-1327.1998.2550369.x. View

5.
Verdonk M, Cole J, Hartshorn M, Murray C, Taylor R . Improved protein-ligand docking using GOLD. Proteins. 2003; 52(4):609-23. DOI: 10.1002/prot.10465. View